$CVS
CVS Health Corp

2013 Q4 Form 10-Q Financial Statement

#000006480313000027 Filed on November 05, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $32.83B $31.93B $30.24B
YoY Change 4.56% 5.61% 13.36%
Cost Of Revenue $26.45B $25.91B $24.58B
YoY Change 5.37% 5.39% 14.35%
Gross Profit $6.338B $6.027B $5.645B
YoY Change 0.7% 6.77% 9.02%
Gross Profit Margin 19.31% 18.87% 18.67%
Selling, General & Admin $4.122B $3.873B $3.833B
YoY Change 3.2% 1.04% 6.65%
% of Gross Profit 65.04% 64.26% 67.9%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $4.122B $3.873B $3.833B
YoY Change 3.2% 1.04% 6.65%
Operating Profit $2.217B $2.154B $1.812B
YoY Change -3.57% 18.87% 14.39%
Interest Expense -$135.0M $125.0M $135.0M
YoY Change -15.63% -7.41% -13.46%
% of Operating Profit -6.09% 5.8% 7.45%
Other Income/Expense, Net
YoY Change
Pretax Income $2.074B $2.032B $1.680B
YoY Change 16.71% 20.95% 17.56%
Income Tax $812.0M $777.0M $669.0M
% Of Pretax Income 39.15% 38.24% 39.82%
Net Earnings $1.265B $1.249B $1.005B
YoY Change 12.44% 24.28% 15.92%
Net Earnings / Revenue 3.85% 3.91% 3.32%
Basic Earnings Per Share $1.06 $1.03 $0.79
Diluted Earnings Per Share $1.05 $1.02 $0.79
COMMON SHARES
Basic Shares Outstanding 1.190B shares 1.218B shares 1.265B shares
Diluted Shares Outstanding 1.226B shares 1.274B shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.177B $1.613B $1.238B
YoY Change 202.68% 30.29% -27.69%
Cash & Equivalents $4.089B $1.505B $1.233B
Short-Term Investments $88.00M $108.0M $5.000M
Other Short-Term Assets $472.0M $401.0M $212.0M
YoY Change -18.2% 89.15% -77.59%
Inventory $11.05B $10.83B $10.49B
Prepaid Expenses
Receivables $8.729B $8.035B $6.407B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $25.33B $21.43B $18.88B
YoY Change 25.61% 13.52% -0.31%
LONG-TERM ASSETS
Property, Plant & Equipment $8.615B $8.749B $8.369B
YoY Change -0.2% 4.54% -3.16%
Goodwill $26.54B $26.55B $26.42B
YoY Change 0.56% 0.48%
Intangibles $9.529B $9.587B $9.801B
YoY Change -2.3% -2.18%
Long-Term Investments
YoY Change
Other Assets $1.515B $1.487B $1.325B
YoY Change 18.36% 12.23% 8.78%
Total Long-Term Assets $46.20B $46.37B $45.92B
YoY Change 0.31% 0.99% -0.86%
TOTAL ASSETS
Total Short-Term Assets $25.33B $21.43B $18.88B
Total Long-Term Assets $46.20B $46.37B $45.92B
Total Assets $71.53B $67.81B $64.80B
YoY Change 8.01% 4.64% -0.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.548B $5.412B $5.091B
YoY Change 9.43% 6.31% -32.03%
Accrued Expenses $4.768B $3.940B $3.618B
YoY Change 8.09% 8.9% -15.05%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $814.0M $825.0M
YoY Change -100.0% -1.33% 55.66%
Long-Term Debt Due $561.0M $572.0M $5.000M
YoY Change 11120.0% 11340.0% -92.96%
Total Short-Term Liabilities $15.43B $15.10B $13.26B
YoY Change 9.01% 13.84% 7.39%
LONG-TERM LIABILITIES
Long-Term Debt $12.84B $8.819B $9.210B
YoY Change 40.6% -4.25% -9.41%
Other Long-Term Liabilities $1.421B $1.563B $1.513B
YoY Change -5.33% 3.3% 12.24%
Total Long-Term Liabilities $14.26B $10.38B $10.72B
YoY Change 34.12% -3.18% -6.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.43B $15.10B $13.26B
Total Long-Term Liabilities $14.26B $10.38B $10.72B
Total Liabilities $29.69B $25.48B $23.99B
YoY Change 19.78% 6.23% -13.61%
SHAREHOLDERS EQUITY
Retained Earnings $28.49B $27.55B $24.12B
YoY Change 13.98% 14.21%
Common Stock $17.00M $17.00M $17.00M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $20.17B $18.46B $15.94B
YoY Change 23.96% 15.84%
Treasury Stock Shares 500.0M shares 473.0M shares 415.0M shares
Shareholders Equity $37.94B $38.53B $36.92B
YoY Change
Total Liabilities & Shareholders Equity $71.53B $67.81B $64.80B
YoY Change 8.01% 4.64% -0.7%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income $1.265B $1.249B $1.005B
YoY Change 12.44% 24.28% 15.92%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $1.538B $1.703B $923.0M
YoY Change -11.15% 84.51% -52.96%
INVESTING ACTIVITIES
Capital Expenditures -$654.0M -$526.0M -$496.0M
YoY Change -8.66% 6.05% 8.3%
Acquisitions
YoY Change
Other Investing Activities $441.0M -$3.000M $398.0M
YoY Change 782.0% -100.75% -1120.51%
Cash From Investing Activities -$213.0M -$529.0M -$98.00M
YoY Change -68.02% 439.8% -80.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.261B -850.0M -1.415B
YoY Change -236.62% -39.93% -28.75%
NET CHANGE
Cash From Operating Activities 1.538B 1.703B 923.0M
Cash From Investing Activities -213.0M -529.0M -98.00M
Cash From Financing Activities 1.261B -850.0M -1.415B
Net Change In Cash 2.586B 324.0M -590.0M
YoY Change 1721.13% -154.92% 13.24%
FREE CASH FLOW
Cash From Operating Activities $1.538B $1.703B $923.0M
Capital Expenditures -$654.0M -$526.0M -$496.0M
Free Cash Flow $2.192B $2.229B $1.419B
YoY Change -10.42% 57.08% -41.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5412000000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5070000000 USD
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8035000000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6473000000 USD
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3940000000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4051000000 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-194000000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-181000000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-198000000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29120000000 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29653000000 USD
CY2012Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
121000000 USD
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
124000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
370000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
362000000 USD
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7900000 shares
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8200000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5700000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5100000 shares
CY2013Q3 us-gaap Assets
Assets
67805000000 USD
CY2012Q4 us-gaap Assets
Assets
65912000000 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
21432000000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
19852000000 USD
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1505000000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1375000000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1233000000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1413000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
130000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-180000000 USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4875
CY2012Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.1625
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.675
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2250
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3200000000 shares
CY2012Q4 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
31000000 USD
CY2013Q3 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
31000000 USD
CY2012Q4 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2013Q3 us-gaap Common Stock Shares Held In Employee Trust Shares
CommonStockSharesHeldInEmployeeTrustShares
1000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1667000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1669000000 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1204000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1231000000 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
17000000 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
17000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2748000000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1258000000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1007000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3318000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
0 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3318000000 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1258000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2750000000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1007000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
75530000000 USD
us-gaap Cost Of Revenue
CostOfRevenue
76527000000 USD
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
25933000000 USD
CY2012Q3 us-gaap Cost Of Revenue
CostOfRevenue
24580000000 USD
CY2013Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
9400000000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
663000000 USD
CY2013Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
558000000 USD
CY2013Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3791000000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
3784000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1297000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1412000000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.15
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.80
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.72
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.70
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.79
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.13
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
5000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
21000000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
48000000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
0 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
0 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
0 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 USD
CY2013Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 USD
CY2013Q3 us-gaap Goodwill
Goodwill
26550000000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
26395000000 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
155000000 USD
CY2013Q3 us-gaap Gross Profit
GrossProfit
6035000000 USD
us-gaap Gross Profit
GrossProfit
17452000000 USD
us-gaap Gross Profit
GrossProfit
16209000000 USD
CY2012Q3 us-gaap Gross Profit
GrossProfit
5647000000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1260000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
2755000000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1011000000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
3338000000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2039000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5454000000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1680000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4528000000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1011000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2753000000 USD
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
3338000000 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
1260000000 USD
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.72
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.04
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
2.15
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.80
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.14
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
2.70
CY2013Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.03
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.79
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-5000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-7000000 USD
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-6000000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-7000000 USD
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2013Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
779000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1775000000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
669000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2116000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
2213000000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1530000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
919000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
697000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1518000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
296000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
325000000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
32000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
586000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
39000000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-425000000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-176000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
142000000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
125000000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
68000000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
49000000 USD
CY2012Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8000000 shares
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9587000000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9753000000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
135000000 USD
us-gaap Interest Expense
InterestExpense
399000000 USD
us-gaap Interest Expense
InterestExpense
379000000 USD
CY2013Q3 us-gaap Interest Expense
InterestExpense
125000000 USD
CY2013Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-122000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-374000000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-397000000 USD
CY2012Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-134000000 USD
us-gaap Interest Paid
InterestPaid
369000000 USD
us-gaap Interest Paid
InterestPaid
411000000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
10759000000 USD
CY2013Q3 us-gaap Inventory Net
InventoryNet
10825000000 USD
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
5000000 USD
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000000 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67805000000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
65912000000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13790000000 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
15098000000 USD
CY2013Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
572000000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5000000 USD
CY2013Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
10300000000 USD
CY2013Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8819000000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9133000000 USD
CY2003Q4 us-gaap Loss Contingency Number Of Defendants
LossContingencyNumberOfDefendants
2 entity
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3937000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2498000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1183000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1622000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4940000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4245000000 USD
CY2012Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2000000 USD
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1254000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3331000000 USD
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1006000000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2748000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
4925000000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1814000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
5828000000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
577000000 USD
us-gaap Operating Expenses
OperatingExpenses
11624000000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2161000000 USD
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
401000000 USD
us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
2 acquisition
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
3874000000 USD
us-gaap Operating Expenses
OperatingExpenses
11284000000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
3833000000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1280000000 USD
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1487000000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3000000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15000000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000000 USD
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1000000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2000000 USD
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
1000000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
2000000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1501000000 USD
CY2013Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1563000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4001000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2272000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
829000000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
627000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
303000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
354000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1314000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1330000000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2013Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
84463000000 USD
us-gaap Proceeds From Customers
ProceedsFromCustomers
85408000000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
5000000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
107000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
67826000000 USD
us-gaap Payments To Suppliers
PaymentsToSuppliers
67464000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
10760000000 USD
us-gaap Payments To Suppliers And Employees
PaymentsToSuppliersAndEmployees
10120000000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
2000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
124000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
75000000 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
7000000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
13000000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
677000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
431000000 USD
CY2013Q3 us-gaap Profit Loss
ProfitLoss
1254000000 USD
CY2012Q3 us-gaap Profit Loss
ProfitLoss
1006000000 USD
us-gaap Profit Loss
ProfitLoss
3331000000 USD
us-gaap Profit Loss
ProfitLoss
2746000000 USD
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8749000000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8632000000 USD
CY2013Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
12000000 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
35000000 USD
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
26000000 USD
CY2012Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
8000000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
21000000 USD
CY2012Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
8000000 USD
CY2013Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
10000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
56000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
28000000 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
27551000000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25049000000 USD
us-gaap Revenues
Revenues
93979000000 USD
CY2013Q3 us-gaap Revenues
Revenues
31968000000 USD
us-gaap Revenues
Revenues
91739000000 USD
CY2012Q3 us-gaap Revenues
Revenues
30227000000 USD
us-gaap Sale Leaseback Transaction Gross Proceeds
SaleLeasebackTransactionGrossProceeds
156000000 USD
us-gaap Sale Leaseback Transaction Gross Proceeds
SaleLeasebackTransactionGrossProceeds
427000000 USD
us-gaap Sale Leaseback Transaction Net Proceeds
SaleLeasebackTransactionNetProceeds
156000000 USD
us-gaap Sale Leaseback Transaction Net Proceeds
SaleLeasebackTransactionNetProceeds
427000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
101000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
97000000 USD
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
14.29
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
37000000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
41.07
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
58.40
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M
CY2013Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
814000000 USD
CY2012Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
690000000 USD
CY2013Q3 us-gaap Short Term Investments
ShortTermInvestments
108000000 USD
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
5000000 USD
CY2013Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
25000000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
73000000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
76000000 USD
CY2012Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
25000000 USD
CY2013Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
38534000000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
37704000000 USD
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
435000000 shares
CY2013Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
473000000 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
16270000000 USD
CY2013Q3 us-gaap Treasury Stock Value
TreasuryStockValue
18462000000 USD
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1274000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1290000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1234000000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1226000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1226000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1281000000 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1218000000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1265000000 shares
CY2013Q3 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
4360000000 USD
CY2012Q4 cvs Claims And Discounts Payable
ClaimsAndDiscountsPayable
3974000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
87000000 USD
cvs Deferred Income Tax Expense Benefit And Other Non Cash Items
DeferredIncomeTaxExpenseBenefitAndOtherNonCashItems
129000000 USD
CY2013Q3 cvs Gainonantitrustlegalsettlementwithaprescriptiondrugmanufacturer
Gainonantitrustlegalsettlementwithaprescriptiondrugmanufacturer
72000000 USD
CY2013Q3 cvs Guaranteed Store Leases
GuaranteedStoreLeases
74 store_lease
cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
CY2013Q3 cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
CY2012Q3 cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
cvs Incremental Common Shares Attributable To Restricted Stock Units
IncrementalCommonSharesAttributableToRestrictedStockUnits
1000000 shares
cvs Intersegment Transactions Number Of Type Of Transactions
IntersegmentTransactionsNumberOfTypeOfTransactions
2 type_of_transaction
cvs Minimum Initial Maturities Of Short Term Investments
MinimumInitialMaturitiesOfShortTermInvestments
P3M
CY2003Q4 cvs Number Of Competitors Against Whom Putative Actions Are Filed
NumberOfCompetitorsAgainstWhomPutativeActionsAreFiled
2 competitor
CY2003Q4 cvs Number Of Pharmacies Filing Putative Action
NumberOfPharmaciesFilingPutativeAction
2 pharmacy
cvs Other Comprehensive Income Loss Before Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax
-15000000 USD
CY2013Q3 cvs Other Comprehensive Income Loss Before Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax
3000000 USD
cvs Purchase Of Noncontrolling Interest In Subsidiary
PurchaseOfNoncontrollingInterestInSubsidiary
26000000 USD
cvs Purchase Of Noncontrolling Interest In Subsidiary
PurchaseOfNoncontrollingInterestInSubsidiary
0 USD
CY2013Q3 cvs Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1000000 USD
cvs Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-2000000 USD
CY2012Q3 cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
841000000 USD
CY2013Q3 cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
1100000000 USD
cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
2500000000 USD
cvs Segment Reporting Information Revenues Recorded By More Than One Reporting Segment
SegmentReportingInformationRevenuesRecordedByMoreThanOneReportingSegment
3100000000 USD
dei Amendment Flag
AmendmentFlag
0
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000064803
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1190254167 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CVS CAREMARK CORPORATION

Files In Submission

Name View Source Status
0000064803-13-000027-index-headers.html Edgar Link pending
0000064803-13-000027-index.html Edgar Link pending
0000064803-13-000027.txt Edgar Link pending
0000064803-13-000027-xbrl.zip Edgar Link pending
cvs-20130930.xml Edgar Link completed
cvs-20130930.xsd Edgar Link pending
cvs-20130930_cal.xml Edgar Link unprocessable
cvs-20130930_def.xml Edgar Link unprocessable
cvs-20130930_lab.xml Edgar Link unprocessable
cvs-20130930_pre.xml Edgar Link unprocessable
cvs20130930-10q.htm Edgar Link pending
cvs20130930ex311.htm Edgar Link pending
cvs20130930ex312.htm Edgar Link pending
cvs20130930ex321.htm Edgar Link pending
cvs20130930ex322.htm Edgar Link pending
exhibit151q3eyconsent.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending